|
| Press Releases |
|
 |
|
| Thursday, August 29, 2019 |
|
|
中国生物制药公布2019年中期业绩 |
中国领先的创新驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）今天公布截至2019年6月30日止六个月（「回顾期」）之未经审核财务业绩。
more info >> |
|
|
中國生物製藥公佈2019年中期業績 |
中國領先的創新驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）今天公佈截至2019年6月30日止六個月（「回顧期」）之未經審核財務業績。
more info >> |
|
|
Sino Biopharmaceutical Announces 2019 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced today its unaudited interim results for the six months ended 30 June 2019 (the "review period").
more info >> |
|
| Wednesday, May 22, 2019 |
|
|
中国生物制药公布2019年第一季度业绩 |
中国领先的创新驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2019年3月31日止三个月（「回顾期」）之未经审核财务业绩。
more info >> |
|
|
中國生物製藥公佈2019年第一季度業績 |
| 中國領先的創新驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2019年3月31日止三個月（「回顧期」）之未經審核財務業績。 more info >> |
|
|
Sino Biopharmaceutical Announces 2019 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2019 ("the review period").
more info >> |
|
| Monday, April 1, 2019 |
|
|
中国生物制药2018年度业绩再创新高 |
中国领先的创新驱动型医药集团—中国生物制药有限公司（「中国生物制药」或「公司」，连同附属公司统称「集团」）（股票编号：1177）公布截至2018年12月31日止年度之全年业绩。
more info >> |
|
|
中國生物製藥2018年度業績再創新高 |
中國領先的創新驅動型醫藥集團—中國生物製藥有限公司（「中國生物製藥」或「公司」，連同附屬公司統稱「集團」）（股票編號：1177）公佈截至2018年12月31日止年度之全年業績。
more info >> |
|
|
Sino Biopharmaceutical's 2018 Annual Results Reaches New Height |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its annual results for the year ended 31 December 2018.
more info >> |
|
| Monday, November 26, 2018 |
|
|
中国生物制药公布2018年第三季度业绩 |
中国生物制药有限公司（「中国生物制药」或「集团」）（股票编号：1177）公布截至2018年9月30日止九个月之第三季度未经审核财务业绩（「回顾期」），这是中国生物制药由2018年9月10日起获纳入恒生指数成分股后首份季度业绩。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
三菱重工、西豪州パースに脱炭素事業の営業拠点を設立
Apr 7, 2025 14:00: JST
|
|
|
科技創新價值凸顯 優然牧業2024年盈利提升 現金EBITDA同比增38.3%至53.25億元
Apr 7, 2025 13:54 HKT/SGT
|
|
|
陽光保險：業績穩增彰顯發展韌性 香港資管開業再啟新程
Apr 7, 2025 13:08 HKT/SGT
|
|
|
通通AI社交集團公佈2024年度業績
Apr 7, 2025 13:06 HKT/SGT
|
|
|
洲際航天科技業績期聚焦：百星展覽展示AI賦能衛星製造的未來
Apr 7, 2025 13:03 HKT/SGT
|
|
|
海通恒信：深耕金融“五篇大文章” 2024年業務布局持續優化
Apr 7, 2025 13:01 HKT/SGT
|
|
|
又又又派錢了，很賺錢嗎？
Apr 7, 2025 12:58 HKT/SGT
|
|
|
BCQ Achieves Dual Growth in 2024 Revenue and Net Profit Attributable to Shareholders
Apr 7, 2025 12:24 HKT/SGT
|
|
|
Katalon Study Reveals 20% of AI Testers Fear Job Loss
Apr 7, 2025 10:03 HKT/SGT
|
|
|
Forexiro Makes Its Debut at Cyprus Trading Event, Offering Structured Gold Trading on H4
Apr 7, 2025 10:00: JST
|
|
|
Nghiên cứu của Katalon tiết lộ 20% người kiểm tra AI sợ mất việc
Apr 7, 2025 09:34 HKT/SGT
|
|
|
Forexiro Makes Its Debut at Cyprus Trading Event, Offering Structured Gold Trading on H4
Apr 7, 2025 09:00 HKT/SGT
|
|
|
Integration of ION Mobility's assets and IP, set to accelerate TVS Motor's EV footprint in South East Asian markets
Apr 7, 2025 08:30 HKT/SGT
|
|
|
EdgePoint Towers Appoints Ravin Vickneswaran as Chief Operating Officer
Apr 7, 2025 03:06 HKT/SGT
|
|
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
Apr 6, 2025 20:30 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
